FSA encourages CBD brands to reformulate in updated guidance

Goodrays

The FSA said it was now “recommending that products are reformulated” in line with evidence published by its independent scientific committee on CBD and THC

The FSA is to encourage businesses to reformulate products to meet its CBD provisional acceptable daily intake (ADI) of 10 mg per day, and a new THC safe upper limit of 0.07 mg per day.

Already have an account? Sign in here

Want access to this article?

Register for LIMITED access

REGISTER FOR FREE

Get PREMIUM access for £1 a week

SUBSCRIBE NOW